This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kwon, C.-H. Articles by Parada, L. F. Search for Related Content PubMed PubMed Citation Articles by Kwon, C.-H. Articles by Parada, L. F.

Pten Haploinsufficiency Accelerates Formation of High-Grade Astrocytomas

Departments of ¹ Developmental Biology, ² Radiology, and ³ Pathology, University of Texas Southwestern Medical Center, Dallas, Texas; ⁴ Department of Developmental and Cell Biology, University of California, Irvine, California; and ⁵ Department of Molecular and Medical Pharmacology, University of California at Los Angeles David Geffen School of Medicine, Los Angeles, California

Requests for reprints: Luis F. Parada, Department of Developmental Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9133. Phone: 214-648-1822; Fax: 214-648-1960; E-mail: luis.parada{at}utsouthwestern.edu.

Key Words: Pten • Nf1 • p53 • neural stem cell • high-grade astrocytomas • mouse

We previously reported that central nervous system (CNS) inactivation of Nf1 and p53 tumor suppressor genes in mice results in the development of low-grade to high-grade progressive astrocytomas. When the tumors achieve high grade, they are frequently accompanied by Akt activation, reminiscent of the frequent association of PTEN mutations in human high-grade glioma. In the present study, we introduced CNS heterozygosity of Pten into the Nf1/p53 astrocytoma model. Resulting mice had accelerated morbidity, shortened survival, and full penetrance of high-grade astrocytomas. Haploinsufficiency of Pten accelerated formation of grade 3 astrocytomas, whereas loss of Pten heterozygosity and Akt activation coincided with progression into grade 4 tumors. These data suggest that successive loss of each Pten allele may contribute to de novo formation of high-grade astrocytoma and progression into glioblastoma, respectively, thus providing insight into the etiology of primary glioblastoma. The presence of ectopically migrating neural stem/progenitor lineage cells in presymptomatic Pten-deficient mutant brains supports the notion that these tumors may arise from stem/progenitor cells. [Cancer Res 2008;68(9):3286–94]

This article has been cited by other articles:

				S. R. Alcantara Llaguno, J. Chen, and L. F. Parada Signaling in Malignant Astrocytomas: Role of Neural Stem Cells and Its Therapeutic Implications Clin. Cancer Res., December 1, 2009; 15(23): 7124 - 7129. [Abstract] [Full Text] [PDF]

				N. R. Leslie P-REX2a Driving Tumorigenesis by PTEN Inhibition Sci. Signal., October 27, 2009; 2(94): pe68 - pe68. [Abstract] [Full Text] [PDF]

				L. Lin, J. Chen, J. A. Richardson, and L. F. Parada Mice lacking neurofibromin develop gastric hyperplasia Am J Physiol Gastrointest Liver Physiol, October 1, 2009; 297(4): G751 - G761. [Abstract] [Full Text] [PDF]

				G. Frosina DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy Mol. Cancer Res., July 1, 2009; 7(7): 989 - 999. [Abstract] [Full Text] [PDF]

				J. T. Huse, C. Brennan, D. Hambardzumyan, B. Wee, J. Pena, S. H. Rouhanifard, C. Sohn-Lee, C. le Sage, R. Agami, T. Tuschl, et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo Genes & Dev., June 1, 2009; 23(11): 1327 - 1337. [Abstract] [Full Text] [PDF]

				X. SUN, J. HUANG, T. HOMMA, D. KITA, H. KLOCKER, G. SCHAFER, P. BOYLE, and H. OHGAKI Genetic Alterations in the PI3K Pathway in Prostate Cancer Anticancer Res, May 1, 2009; 29(5): 1739 - 1743. [Abstract] [Full Text] [PDF]

				T. W. Abel, C. Clark, B. Bierie, A. Chytil, M. Aakre, A. Gorska, and H. L. Moses GFAP-Cre-Mediated Activation of Oncogenic K-ras Results in Expansion of the Subventricular Zone and Infiltrating Glioma Mol. Cancer Res., May 1, 2009; 7(5): 645 - 653. [Abstract] [Full Text] [PDF]

				A. M. Puzio-Kuter, M. Castillo-Martin, C. W. Kinkade, X. Wang, T. H. Shen, T. Matos, M. M. Shen, C. Cordon-Cardo, and C. Abate-Shen Inactivation of p53 and Pten promotes invasive bladder cancer Genes & Dev., March 15, 2009; 23(6): 675 - 680. [Abstract] [Full Text] [PDF]

				E. Samuelson, C. Hedberg, S. Nilsson, and A. Behboudi Molecular classification of spontaneous endometrial adenocarcinomas in BDII rats Endocr. Relat. Cancer, March 1, 2009; 16(1): 99 - 111. [Abstract] [Full Text] [PDF]

				S. A. Llaguno, J. Chen, C.-H. Kwon, and L.F. Parada Neural and Cancer Stem Cells in Tumor Suppressor Mouse Models of Malignant Astrocytoma Cold Spring Harb Symp Quant Biol, November 6, 2008; (2008) sqb.2008.73.005v1. [Abstract] [PDF]